European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Targin. By Mundipharma, Targin is a fixed combination of prolonged-release oxycodone/naloxone, and is a second-line symptomatic treatment of patients with severe to very severe idiopathic restless legs syndrome (RLS), after failure of dopaminergic therapy.
Dental Sleep Solutions, which offers end-to-end implementation solutions for dental practices via its flagship product DS3 Software, has entered a partnership with GoGo Billing, which manages billing services for DSM, TMD, and other medically necessary dental treatments.
Research from UK bedding specialist Slumberdown finds the majority of UK adults who have left their heating on overnight to stay warm in bed are suffering with ill health as a result.
ResMed introduced myAir, a new personalized therapy management application for patients with sleep-disordered breathing.
ResMed announced significant improvement to U-Sleep, its patient management platform, which allows home medical equipment providers (HMEs) to quickly and effectively manage patients with sleep apnea and respiratory conditions.
Philips Respironics showcased “The ANSWER,” a comprehensive business transformation process that connects product, technology, and workflow innovations for both sleep and respiratory care management, at Medtrade Fall.
Our species’ waking and sleeping cycles–shaped in millions of years of evolution–have been turned upside down within a single century with the advent of electric lighting and airplanes.
Researchers studying how big the Internet is have found that it “sleeps,” almost like a living creature.
Dr Joseph Takahashi, chairman of Neuroscience at UT Southwestern Medical Center since 2009, has been elected to the Institute of Medicine (IOM), a component of the prestigious National Academies of Sciences.
Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania’s School of Medicine and School of Arts and Sciences have teased apart the separate biological responses of the human eye to blue light, revealing an unexpected contest for control.